Related Experiment Video
Updated: Dec 21, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via
Liang-Yi Zhu1, Xiao-Yu Wu1, Xiao-Dan Liu1,2
1Department of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center.
Abstract:
Medulloblastomas (MBs) are currently divided into 4 molecular subgroups: WNT, SHH, Group 3, and Group 4. Among them, Group 3 MB has the worst prognosis, and 40%-50% of Group 3 cases are already metastatic at the time of diagnosis. Emerging evidence indicates that exosomes drive tumor invasion, but very little is known about exosomes in MBs. In this study, we initially discovered that exosomes isolated from Group 3 MB cell lines altered in vitro behaviors of a less invasive SHH MB cell line and yielded a much more aggressive phenotype. RNA-sequencing analysis revealed 7 exosomal miRNAs with markedly different expression levels between the SHH and Group 3 MB cell lines. They were all predicted to be related to the Ras/MAPK pathway according to the Kyoto Encyclopedia of Genes and Genomes data analysis. Increased expression of miR-181a-5p, miR-125b-5p, and let-7b-5p was further confirmed in Group 3 MB cells with real-time PCR and was shown to increase in vitro invasion and migratory abilities of tumor cells through the activation of ERK in Ras/MAPK pathway. Collectively, our findings suggest that exosomal miRNAs have a critical role in MB progression in vitro and might serve as diagnostic biomarkers and therapeutic targets.
Insights
Exosomes from Group 3 medulloblastoma (MB) promote tumor invasion. Specific exosomal microRNAs (miRNAs) activate the Ras/MAPK pathway, driving MB progression and offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Medulloblastomas (MBs) comprise four molecular subgroups, with Group 3 MB exhibiting the poorest prognosis and high metastatic rates.
- Exosomes are implicated in tumor invasion, yet their role in MB remains largely unexplored.
Purpose of the Study:
- To investigate the role of exosomes in medulloblastoma progression, particularly in Group 3 MB.
- To identify specific exosomal components contributing to MB invasiveness and potential therapeutic targets.
Main Methods:
- Isolation of exosomes from Group 3 and SHH medulloblastoma cell lines.
- In vitro analysis of exosome-mediated changes in MB cell line behavior.
- RNA-sequencing and real-time PCR to identify and validate exosomal microRNAs (miRNAs).
- Analysis of Ras/MAPK pathway activation, including ERK signaling.
Main Results:
- Exosomes from Group 3 MB cells induced a more aggressive phenotype in less invasive SHH MB cells.
- RNA-sequencing identified 7 differentially expressed exosomal miRNAs between Group 3 and SHH MB.
- Increased expression of miR-181a-5p, miR-125b-5p, and let-7b-5p in Group 3 MB cells.
- These miRNAs enhanced in vitro invasion and migration by activating the Ras/MAPK pathway (ERK).
Conclusions:
- Exosomal miRNAs play a crucial role in medulloblastoma progression in vitro.
- Specific exosomal miRNAs, such as miR-181a-5p, miR-125b-5p, and let-7b-5p, are key drivers of Group 3 MB aggressiveness.
- These exosomal miRNAs represent potential diagnostic biomarkers and therapeutic targets for medulloblastoma.
Related Concept Videos
The Ras Gene
Ras is a...
MAPK Signaling Cascades
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

